Investigation of the effect of curcumin in Multiple Sclerosis
Phase 3
- Conditions
- Multiple Sclerosis.Demyelinating diseases of the central nervous system
- Registration Number
- IRCT20200614047766N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 96
Inclusion Criteria
The study subjects must have RRMS type Ms disease
They are 18 to 50 years old and EDSS (disease incapacity severity) must be less than 4
Patients who have been diagnosed with MS for at least one year
Patients who do not have a specific digestive problem (gastric and duodenal ulcers, irritable bowel syndrome, indigestion)
Not sensitive to curcumin
They do not receive zinc or selenium supplements
Antioxidant corticosteroids, such as vitamin E-A-D, have not been used for at least the past two weeks.
They are not pregnant
Don't be a breastfeeding woman
They do not have special liver or kidney problems
Exclusion Criteria
Lack of willingness of the patient to continue cooperation
patients with mental disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method